Skip to main content
NCBI home page
Science Progress logoLink to Science Progress
. 2019 Feb 27;84(2):105–124. doi: 10.3184/003685001783239014

Environmental Echoes

John L Stanford 1,2, Cynthia A Stanford 1, John M Grange 1,3
PMCID: PMC10367513  PMID: 11525013

Abstract

Allergy, auto immunity and cancer are becoming more prevalent in the developed world. One explanation might be that the immune system required to protect us from such problems is being inadequately trained, perhaps due to our increased separation from the environment which has shaped our mutating genes since we emerged from the primaeval ooze. Those infections which were the essential primers of our immunity are being prevented and action is needed to refocus the immune response without exposing us to the diseases of the past. In this paper we assess our place in relation to the environment and consider ways in which the situation can be redressed. There are considerable similarities between the immune system and human consciousness. Both enter the world in considerable ignorance of the events awaiting them, yet with the genetic ability, endowed by millennia of selection and evolution, to experience the world, to interpret and act on the experiences and to retain memory of the experiences. In both systems, maternal influences and early environmental encounters have profound effects on determining the patterns of subsequent responses. Ideally the ‘learned’ responses will benefit or protect the individual but inappropriate responses may lead to self damage. As the environment has altered irrevocably, attention must be paid to regulating the balance of immunological responsiveness to that expected of the normal immunological learning process. This should be possible by novel vaccination strategies.

Full Text

The Full Text of this article is available as a PDF (192.8 KB).

References

  • 1.Woolcock A.J., & Peat J.K. (1997) Evidence for the increase in asthma worldwide. Ciba Found. Symp., 206, 122–134. [DOI] [PubMed] [Google Scholar]
  • 2.Liccarde G., Cazzola M., D'Amato M., & D'Amato G. (2000) Pets and cockroaches: two increasing causes of respiratory allergy in indoor environments. Characteristics of airways sensitization and prevention strategies. Respir. Med., 94, 1109–1118. [DOI] [PubMed] [Google Scholar]
  • 3.Mannino D.M., Homa D.M., Pertowski C.A. et al. (1998) Surveillance for asthma – United States, 1960-1995. Morbid. Mortal. Wkly Rec., 47–SS–1, 1–28. [PubMed] [Google Scholar]
  • 4.Murray C.J.L., & Lopez A.D, eds. (1996) The global burden of disease: a comprehensive assessment of mortality and disability from diseases, injuries and risk factors in 1990 and projected to 2020. Harvard University Press, Cambridge MA. [Google Scholar]
  • 5.World Health Organization. (1997) World Health Report 1997. Geneva: World Health Organization. [Google Scholar]
  • 6.Tomatis L. (1997) Poverty and cancer. L.A.R.C: Sci. Publ., 138, 25–39. [PubMed] [Google Scholar]
  • 7.Pabst H.F., Spady D.W., Pilarski L.M. et al. (1997) Differential modulation of the immune response by breast- or formula-feeding of infants. Acta. Paediatr, 86, 1291–1297. [DOI] [PubMed] [Google Scholar]
  • 8.Rigas A., Rigas B., Glassman M., Yen Y.Y., Lan S.J., Petridou E., Hsieh C.C., & Trichopoulos D. (1993) Breast-feeding and maternal smoking in the etiology of Crohn's disease and ulcerative colitis in childhood. Ann. Epidemiol, 3, 387–392. [DOI] [PubMed] [Google Scholar]
  • 9.Stanford J.L., Shield M.J., & Rook G.A.W. (1981) Hypothesis 1. How environmental mycobacteria may predetermine the protective efficacy of BCG. Tubercle, 62, 55–62. [DOI] [PubMed] [Google Scholar]
  • 10.Fine P.E. (1998) Vaccines, genes and trials. Novartis. Found Symp., 217, 57–69. [DOI] [PubMed] [Google Scholar]
  • 11.Aaby P., Shaheen S.O., Heyes C.B., Goudiaby A., Hall A.J., Shiell A.W., Jensen H., & Marchant A. (2000) Early BCG vaccination and reduction of atopy in Guinea-Bissau. Clin. Exp. Allergy, 30, 644–650. [DOI] [PubMed] [Google Scholar]
  • 12.Grange J.M., & Stanford J.L. (1990) BCG vaccination and cancer. Tubercle, 71, 61–64. [DOI] [PubMed] [Google Scholar]
  • 13.Challacombe S.J. (1996) Does fluoridation harm immune function? Commun. Dent. Hlth., 13 suppl 2, 69–71. [PubMed] [Google Scholar]
  • 14.Bretscher P.A., Wei G., Menon J.N., & Bielefeldt-Ohmann H. (1992) Establishment of stable, cell mediated immunity that makes “susceptible” mice resistant to Leishmania major. Science, 257, 539–542. [DOI] [PubMed] [Google Scholar]
  • 15.Donohue H., Overend E., & Stanford J.L. (1997) A longitudinal study of environmental mycobacteria on a farm in south-west England. J Appl. Microbiol., 82, 57–67. [DOI] [PubMed] [Google Scholar]
  • 16.Bahr G.M., Chugh T.D., Behbehani K. et al. (1987) Unexpected findings amongst skin test responses to mycobacteria in BCG vaccinated Kuwaiti school children. Tubercle, 68, 105–111. [DOI] [PubMed] [Google Scholar]
  • 17.Zaman R. (1991) Characterization of mycobacteria isolated from patients in western Saudi Arabia with tuberculosis and suspected tuberculosis and the response of the patients to tuberculins. PhD Thesis, University of London. [Google Scholar]
  • 18.Burge P.S., Finnegan M., Horsfield N. et al. (1985) Occupational asthma in a factory with a contaminated humidifier. Thorax, 40, 248–254. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Ponninghaus J.M., Fine P.E.M., Sterne J.A.C. et al. (1992) Efficacy of BCG vaccine against leprosy and tuberculosis in Northern Malawi. Lancet, 339, 636–639. [DOI] [PubMed] [Google Scholar]
  • 20.Dong C., & Flavell RA. (2001) Th1 and Th2 cells. Curr. Opin. Hematol., 8, 47–51. [DOI] [PubMed] [Google Scholar]
  • 21.Roncarolo M-G., & Levings M.K. (2000) The role of different subsets of T regulatory cells in controlling autoimmunity. Curr. Opin. Immunol., 12, 676–683. [DOI] [PubMed] [Google Scholar]
  • 22.Baker R., Zumla A., & Rook G.A.W. (1996) Tuberculosis, steroid metabolism and immunity. Q. J. Med., 89, 387–394. [Google Scholar]
  • 23.Holt P.G. (1999) Potential role of environmental factors in the etiology and pathogenesis of atopy: a working model. Environ. Hith. Perspect., 107 Suppl 3, 485–487. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Martinez F.D., & Holt P.G. (1999) Role of microbial burden in aetiology of allergy and asthma. Lancet, 354 Suppl 2, 12–15. [DOI] [PubMed] [Google Scholar]
  • 25.Riedler J., Eder W., Oberfeld G., & Schreuer M. (2000) Austrian children living on a farm have less hay fever, asthma and allergic sensitization. Clin. Exp. Allergy, 30, 529–537. [DOI] [PubMed] [Google Scholar]
  • 26.Ball T.M., Castro-Rodriguez J.A., Griffith K.A. et al. (2000) Siblings, daycare attendance, and the risk of asthma and wheezing during childhood. N. Engl. J Med., 343, 538–543. [DOI] [PubMed] [Google Scholar]
  • 27.Gereda J.E., Leung D.Y., Thatayatikom A. et al. (2000) Relation between house-dust endotoxin exposure, type 1 T-cell development, and allergen sensitisation in infants at high risk of asthma. Lancet, 355, 1680–1683. [DOI] [PubMed] [Google Scholar]
  • 28.Rook G.A., & Stanford J.L. (1998) Give us this day our daily germs. Immunol. Today, 19, 113–116. [DOI] [PubMed] [Google Scholar]
  • 29.Shirakawa T., Enomoto T., Shimazu S., & Hopkin J.M. (1997) The inverse association between tuberculin response and atopic disorder. Science, 275, 77–79. [DOI] [PubMed] [Google Scholar]
  • 30.Matricardi P.M., Rosmini F., Riondino S., Fortini M., Ferrigno L., Rapicetta M., & Bonini S. (2000) Exposure to foodborne and orofecal microbes versus airborne viruses in relation to atopy and allergic asthma: epidemiological study. Brit. Med. J., 320, 412–417. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Cohen I.R., & Young D.B. (1991) Autoimmunity, microbial immunity and the immunological homunculus. Immunol. Today, 12, 105–110. [DOI] [PubMed] [Google Scholar]
  • 32.Nishimura T., Nakui M., Sato M. et al. (2000) The critical role of Th1-dominant immunity in tumor immunology. Cancer Chemother. Pharmacol., 46 Suppl, S52–S61 [DOI] [PubMed] [Google Scholar]
  • 33.Stanford J.L. Stanford C.A., Baban B., & Grange J.M. (1999) Therapeutic vaccination for cancer: the potential value of mycobacterial products. Int. J. Pharmaceut. Med., 12, 191–195. [Google Scholar]
  • 34.de Morgan C. (1874) On cancer. The Retrospect of Medicine, 69, 34–39. [Google Scholar]
  • 35.Coley W.B. (1991) The treatment of malignant tumors by repeated inoculations of erysipelas. Historical article reprinted in Clin. Orthop., 262, 3–11. [PubMed] [Google Scholar]
  • 36.Kömel K.F., Pfahlberg A., Mastrangelo G. et al. (1999) Infections and melanoma risk: results of a multicentre EORTC case-control study. Melanoma Res., 9, 511–519. [PubMed] [Google Scholar]
  • 37.Le Van Truoc, Ho Minh Ly, Nguyen Kim Thuy, Dang Duc Trach, Stanford C.A., & Stanford J.L. (2001) Vaccination against leprosy at Ben San Leprosy Centre, Ho Chi Minh City, Vietnam. Vaccine, 19, 3451–3458. [DOI] [PubMed] [Google Scholar]
  • 38.Arkwright P.D., & David T.J. (2001) Intra-dermal administration of a killed Mycobacterium vaccae suspension (SRL 172) is associated with improvement in atopic dermatitis in children with moderate to severe disease. J. Allergy Clin. Immunol., 107, 531–534. [DOI] [PubMed] [Google Scholar]
  • 39.Hopkin J.M., Ferry B., Coull P. et al. (1998) Mycobacterial immunisation in grass pollen asthma and rhinitis. Thorax, 53, 63.9577525 [Google Scholar]
  • 40.Ramu G., Prema G.D., Balakrishnan S., Shanker Narayan N.P., & Stanford J.L. (1990) A preliminary report on the immunotherapy of psoriasis. Ind. Med. Gazette, 124, 381–382. [Google Scholar]
  • 41.The Genome International Sequencing Consortium. (2001) Initial sequencing and analysis of the human genome. Nature, 409, 860–921. [DOI] [PubMed] [Google Scholar]
  • 42.Shukia N., Chan Y., Ingledew N. et al. (1998) Role of heat shock protein 65 kDa on vascular smoothe muscle proliferation. Abstract: International conference on heat shock proteins in immune response, Farmington 1998. Stress Chaperones, 3, Suppl 1, 23–24. [Google Scholar]
  • 43.Stanford J.L., Stanford C.A., Ghazi Saidi K. et al. (1989) Vaccination and skin test studies on the children of leprosy patients. Int. J. Leprosy, 57, 38–44. [PubMed] [Google Scholar]
  • 44.Marchant A., Goetghebuer T., Ota M.O. et al. (1999) Newborns develop a Th1-type immune response to Mycobacterium bovis bacillus Calmette-Guerin vaccination. J. Immunol., 163, 2249–2255. [PubMed] [Google Scholar]

Articles from Science Progress are provided here courtesy of SAGE Publications

RESOURCES